[Diagnostics of drug hypersensitivity reactions].

scientific article

[Diagnostics of drug hypersensitivity reactions]. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00105-016-3908-X
P698PubMed publication ID28005146

P50authorChristian MöbsQ45987149
P2093author name stringW Pfützner
P2860cites workUtility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruptionQ81553544
Diagnosing nonimmediate reactions to cephalosporinsQ83416742
Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugsQ84487709
Determining the negative predictive value of provocation tests with beta-lactamsQ84792062
Skin testing and patch testing in non-IgE-mediated drug allergyQ87698771
Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic reviewQ28271185
Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-γ and sFasL memory responseQ28483831
Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells.Q34751819
Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance.Q35519510
Diagnosis of immediate allergic reactions to beta‐lactam antibioticsQ35544062
Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German AllergoloQ35777131
The lymphocyte transformation test in the diagnosis of drug hypersensitivityQ35824801
Diagnostic tests based on human basophils: potentials, pitfalls and perspectives.Q36534669
Update on the evaluation of hypersensitivity reactions to betalactamsQ37365661
Basophil activation tests in the evaluation of immediate drug hypersensitivityQ37502644
International Consensus on drug allergy.Q38201761
In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needsQ38228927
Cellular in vitro diagnosis of adverse drug reactionsQ38539744
The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.Q38551689
In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paperQ39909074
Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy studyQ43034978
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis.Q43253611
Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitizationQ43982212
Detection and quantification of drug-specific T cells in penicillin allergyQ46156607
Cellular allergen stimulation test with acetylsalicylic acid-lysine is not a useful test to discriminate between asthmatic patients with and without acetylsalicylic acid sensitivityQ46228661
Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challengeQ46231257
The usefulness of skin tests to prove drug hypersensitivityQ46485669
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paperQ46912843
In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases.Q53368356
Natural evolution of skin test sensitivity in patients allergic to β-lactam antibioticsQ62130110
Hypersensitivity reactions to drugs: correlation between clinical probability score and laboratory diagnostic proceduresQ70932712
The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificityQ73133577
Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerationsQ73794206
The use of skin testing in the investigation of cutaneous adverse drug reactionsQ77383791
Predictive capacity of histamine release for the diagnosis of drug allergyQ77918446
General considerations for skin test procedures in the diagnosis of drug hypersensitivityQ78048816
CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivityQ79839787
P433issue1
P407language of work or nameGermanQ188
P304page(s)19-28
P577publication date2017-01-01
P1433published inDie DermatologieQ15756740
P1476title[Diagnostics of drug hypersensitivity reactions].
P478volume68

Reverse relations

cites work (P2860)
Q50142530Spättypreaktionen durch oral und parenteral applizierte Arzneimittel
Q90263644[Personalized medicine in allergology]

Search more.